ESR1 and breast carcinoma: The highest expression (by up to 4-fold) (both at baseline and in response to CoCl2) was seen in the ER −ve breast cancer cells (which have a higher proliferation and migration rate in comparison to ER + breast cancer cells), with the lowest expression in the normal epithelial breast cells.